trending Market Intelligence /marketintelligence/en/news-insights/trending/r2q_1npknxamvkcodmhyqw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Brainstorm Cell Therapeutics appoints chief commercial officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Brainstorm Cell Therapeutics appoints chief commercial officer

New York-based biotechnology company Brainstorm Cell Therapeutics Inc. appointed Arturo Araya as chief commercial officer, effective Sept. 4.

Araya has served on Brainstorm's board since February 2017. He served as the global head of commercial for Novartis AG unit Novartis Pharmaceuticals Corp.'s cell and gene therapies unit until 2016.

Brainstorm develops stem cell treatments to treat diseases caused by degeneration of the nervous system.